Chinese nanopore sequencer maker Geneus Technologies obtained CE marking under the EU’s IVDR for its desktop single-molecule nanopore platform, including the G-seq500 sequencer and G-MK02 sequencing chip. Geneus said the certification supports an EU expansion plan for long-read single-molecule sequencing. The company described its approach as using tethered dNTPs with protein nanopore sensing during amplification—distinguishing the method from direct native-DNA nanopore sequencing models used by some competitors. Geneus said the platform targets applications such as amplicon sequencing, microbial genomics, and full-length 16S and targeted human genome sequencing. Geneus raised about RMB 100 million in a Series B++ round last year, and the company said it has a US subsidiary and research center in the Bay Area. For diagnostics and labs, the IVDR mark moves nanopore long-read testing closer to regulated clinical deployment workflows in Europe, potentially expanding the set of platforms available for molecular diagnostics programs.